Company
Headquarters: Hsinchu City, Taiwan
Employees: 130
TW$605.7 Million
TWD as of Jan. 1, 2024
US$19.7 Million
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
EPS Bio Technology Corp. manufactures and sells OEM/ODM glucose meters and strips primarily in Taiwan. It provides blood glucose monitoring systems under the MDT2, EME, EMMU, EMV2, MasterDrive, 2IN1, and R13N names. The company is based in Hsinchu City, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
EPS Bio Technology Corp has the following listings and related stock indices.
Stock: TWSE: 4183 wb_incandescent